Folgen
Massimo Cella
Massimo Cella
Chiesi Farmaceutici S.p.A.
Bestätigte E-Mail-Adresse bei chiesi.com
Titel
Zitiert von
Zitiert von
Jahr
What is the right dose for children?
M Cella, C Knibbe, M Danhof, O Della Pasqua
British journal of clinical pharmacology 70 (4), 597, 2010
1822010
Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model
MYM Peeters, K Allegaert, HJB van Oud-Alblas, M Cella, D Tibboel, ...
Clinical pharmacokinetics 49, 269-275, 2010
812010
A model‐based approach to dose selection in early pediatric development
M Cella, F Gorter de Vries, D Burger, M Danhof, O Della Pasqua
Clinical Pharmacology & Therapeutics 87 (3), 294-302, 2010
752010
Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations?
M Cella, W Zhao, E Jacqz‐Aigrain, D Burger, M Danhof, OD Pasqua
British journal of clinical pharmacology 72 (3), 454-464, 2011
502011
Memantine prevents reference and working memory impairment caused by sleep deprivation in both young and aged Octodon degus
E Tarragon, D Lopez, C Estrada, A Gonzalez-Cuello, CM Ros, Y Lamberty, ...
Neuropharmacology 85, 206-214, 2014
362014
Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models
M Cella, C Knibbe, SN de Wildt, J Van Gerven, M Danhof, O Della Pasqua
British journal of clinical pharmacology 74 (3), 525-535, 2012
272012
Pharmacogenetics and paediatric drug development: issues and consequences to labelling and dosing recommendations
EHJ Krekels, JN Anker, P Baiardi, M Cella, KY Cheng, DM Gibb, H Green, ...
Expert Opinion on Pharmacotherapy 8 (12), 1787-1799, 2007
272007
Impact of simulated lung fluid components on the solubility of inhaled drugs and predicted in vivo performance
S Radivojev, G Luschin-Ebengreuth, JT Pinto, P Laggner, A Cavecchi, ...
International Journal of Pharmaceutics 606, 120893, 2021
212021
Adaptive trials in paediatric development: dealing with heterogeneity and uncertainty in pharmacokinetic differences in children
M Cella, M Danhof, O Della Pasqua
British journal of clinical pharmacology 74 (2), 346-353, 2012
212012
Model‐based assessment of alternative study designs in pediatric trials. Part II: Bayesian approaches
G Smania, P Baiardi, A Ceci, M Cella, P Magni
CPT: pharmacometrics & systems pharmacology 5 (8), 402-410, 2016
122016
Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV‐infected infants and …
W Zhao, M Cella, O Della Pasqua, D Burger, E Jacqz‐Aigrain, ...
British journal of clinical pharmacology 73 (4), 641-650, 2012
122012
Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus …
A Rahman, Y Lamberty, E Schenker, M Cella, S Languille, R Bordet, ...
Plos one 12 (9), e0184822, 2017
112017
Dosing Rationale for Fixed‐Dose Combinations in Children: Shooting From the Hip?
M Cella, F Kloprogge, M Danhof, O Della Pasqua
Clinical Pharmacology & Therapeutics 91 (4), 718-725, 2012
82012
Therapeutic drug monitoring strategies for envarsus in de novo kidney transplant patients using population modelling and simulations
E Henin, M Govoni, M Cella, C Laveille, G Piotti
Advances in Therapy 38, 5317-5332, 2021
52021
Concentration–QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase‐4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT Prolongation
K Jolling, A Äbelö, N Luyckx, MA Nandeuil, M Govoni, M Cella, ...
CPT: Pharmacometrics & Systems Pharmacology 8 (7), 460-468, 2019
52019
Ethnic sensitivity study of the extrafine, single-inhaler, triple therapy beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide pressurized metered dose …
M Cella, J Täubel, I Delestre-Levai, A Tulard, A Vele, G Georges
Clinical Therapeutics 43 (11), 1934-1947. e4, 2021
42021
Bridging strategies for drug combinations in pediatric indications
M Cella, M Danhof, O Della Pasqua
CliNiCAl PhARmACOlOGy & TheRAPeUTiCs 91 (4), 726-733, 2012
32012
Therapeutic drug monitoring strageties for Envarsus in de novo renal transplant patients using population modelling and simulations
E Hénin, M Govoni, G Piotti, M Cella, C Laveille
Poster on Population Approach Group Europe, 2019
22019
Population pharmacokinetic modelling of CHF6001 following dry powder inhalation in healthy volunteers
K Jolling, M Cella, M Govoni, MA Nandeuil, A Lindauer
PAGE Conference, 2018
22018
Model-based comparison of alternative study designs in pediatric trials
G Smania, P Baiardi, M Cella, P Magni
Part II: Bayesian approaches. CPT Pharmacometrics Syst. Pharmacol.(submitted), 2015
12015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20